ACTRN12624000394549尚未招募Unknown
An open-label, uncontrolled feasibility and acceptability trial of a therapist-assisted, online parenting program (‘PiP-Kids Autism’) for parents of autistic children, targeting child depression and anxiety.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Parents/guardians:
- •- of autistic children aged 8 - 11 who live in Australia
- •- who can read and speak English
- •- have internet access
排除标准
- •1. Child does not yet have phrase speech (meaningful multi-word utterances that include an action word such as I am jumping on the trampoline).
- •2. Child has a significant neurologic or metabolic disorder, chromosomal abnormality, motor or sensory impairment, or a life-threatening medical condition.
- •3. Child requires acute treatment or intensive intervention (i.e. behaviours that have resulted in physical injuries to self or others requiring emergency care services more than once in the last 4 months, and/or ongoing behaviours that require ambulance/hospital/police contact).
- •4. Child is currently taking medication for anxiety or depression.
研究者
相似试验
进行中（未招募）
1 期
Can giving medication up the nose and through the lining of the mouth control symptoms as effectively as injections for people approaching the end of life? – Pilot StudyEUCTR2013-005009-30-GBGloucestershire Hospitals NHS Foundation Trust and20
进行中（未招募）
不适用
Study to evaluate the efficacy and safety of human immuneglobulin in patients with primary immune thrombocytopeniaPrimary Immune Thrombocytopenia (ITP)MedDRA version: 15.1Level: LLTClassification code 10023095Term: ITPSystem Organ Class: 100000004851EUCTR2012-000796-16-CZOCTAPHARMA AG30
进行中（未招募）
不适用
Study to evaluate the efficacy and safety of human immuneglobulin in patients with primary immune thrombocytopeniaPrimary Immune Thrombocytopenia (ITP)MedDRA version: 14.1Level: LLTClassification code 10023095Term: ITPSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2012-000796-16-DEOCTAPHARMA AG30
进行中（未招募）
不适用
Study to evaluate the efficacy and safety of human immuneglobulin in patients with primary immune thrombocytopeniaPrimary Immune Thrombocytopenia (ITP)MedDRA version: 15.1Level: LLTClassification code 10023095Term: ITPSystem Organ Class: 100000004851EUCTR2012-000796-16-BGOCTAPHARMA AG30
进行中（未招募）
不适用
Study to evaluate the efficacy and safety of human immuneglobulin in patients with primary immune thrombocytopeniaPrimary Immune Thrombocytopenia (ITP)MedDRA version: 15.1Level: LLTClassification code 10023095Term: ITPSystem Organ Class: 100000004851EUCTR2012-000796-16-PLOCTAPHARMA AG30